Last update 21 Nov 2024
Human Hepatitis B Immunoglubolin (Zhengzhou Raas)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Immunoglobulin |
Synonyms- |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 2013), |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Human Hepatitis B Immunoglubolin (Zhengzhou Raas)静脉注射用人乙型肝炎免疫球蛋白(pH4)联合拉米夫定预防乙肝相关性肝病肝移植术后乙肝病毒再感染临床研究
[Translation] Clinical study on intravenous human hepatitis B immune globulin (pH4) combined with lamivudine in preventing hepatitis B virus reinfection after liver transplantation for hepatitis B-related liver disease
100 Clinical Results associated with Human Hepatitis B Immunoglubolin (Zhengzhou Raas)
Login to view more data
100 Translational Medicine associated with Human Hepatitis B Immunoglubolin (Zhengzhou Raas)
Login to view more data
100 Patents (Medical) associated with Human Hepatitis B Immunoglubolin (Zhengzhou Raas)
Login to view more data
100 Deals associated with Human Hepatitis B Immunoglubolin (Zhengzhou Raas)
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hepatitis B | CN | 01 Jan 2013 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free